Overview

Digital transformation is reshaping respiratory trials, yet critical gaps persist:

• Recruitment barriers: 78% of trials exclude rural/LMIC populations due to site-centric models, worsening health inequity (Khor et al. 2024)
• Regulatory uncertainty: No standardised frameworks exist to validate digital endpoints (e.g., wearables, AI algorithms)
• Implementation costs: Traditional trials cost 30% more than decentralised designs (van Boven et al. 2025)

Why attend?

92% of respiratory professionals demand training on decentralised trial logistics (ERS 2024 survey). This workshop delivers actionable solutions aligned with EU/WHO digital health policies as well as ERS digital health priorities.

Target audience

• Clinicians: Pulmonologists, primary care physicians, pharmacists, nurses, psychologists, physiotherapists, occupational therapists and other allied health professionals
• Researchers: Trial coordinators, data scientists, digital health developers and clinical trial methodologists/leads
• Decision-makers: Policy experts, health economists, hospital administrators
• Industry innovators: Medtech developers, pharmaceutical leads and health insurers with an interest in decentralised trials
• Patients & advocates: ELF representatives, community health workers

Organising committee

Amy Chan

Workshop Chair

 

 

J. van Boven

Workshop Chair

 

Faculty: H. Pinnock, A. Kaplan, A. de Jong, I. Pradipta, I. Hui, D. Drummond, C. Moor, P. Alupo, K. Hansen, I. Cano, A. Gómez, Y. Hamada, Y. Khor, T. Vagg, J. Hurst, H. Musick, M. Gröschel, R. Costello, M. Hew, H. De Keyser, B. Dierick, A. R. Koczulla, R. Muller, C. Nogaard